Evidence map›Paper›PMID 39267745›Full record

ArticleFrontiers in immunology2024

Human papillomavirus disease in

Ehren Dancy, Pamela Stratton, Dominique C Pichard, Beatriz E Marciano, Edward W Cowen, Alison A McBride, Koenraad Van Doorslaer, Melissa A Merideth, Noemi Salmeri, Marybeth S Hughes and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ehren DancyLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Pamela StrattonOffice of the Clinical Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States.
Dominique C PichardNational Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, United States.
Beatriz E MarcianoLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Edward W CowenDermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, United States.
Alison A McBrideLaboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Koenraad Van DoorslaerLaboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Melissa A MeridethOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States.
Noemi SalmeriGynecology/Obstetrics Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
Marybeth S HughesDepartment of Surgery, Eastern Virginia Medical School, Norfolk, VA, United States.
Theo HellerLiver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States.
Mark PartaRetired, Bethesda, MD, United States.
Dennis D HicksteinCenter for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Heidi H KongDermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, United States.
Steven M HollandLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Christa S ZerbeLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Patients with pathogenic variants in the GATA Binding Protein 2 ( Methods: A 17-year retrospective review of medical records, including laboratory, histopathology and cytopathology records was performed for patients diagnosed with Results: Of 68 patients with Conclusion: Females with

Indexed as

GATA2 DeficiencyGATA2 Transcription FactorGenetic Predisposition to DiseasePapillomavirus InfectionsAdolescentAdultAnus NeoplasmsFemaleGenital Neoplasms, FemaleHaploinsufficiencyHuman Papillomavirus VirusesHumansMalePapillomaviridaeRetrospective StudiesYoung AdultGATA2 protein, humanGATA2 Transcription FactorGATA2 haploinsufficiencyhematopoietic stem cell transplantationhigh-grade squamous epithelial lesionHPVHPV vaccinationHSCT or HCTHSILhuman papillomavirus

Identifiers

PMID39267745
PMCPMC11390362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.